SCHOOL OF MEDICINE
“Received a five-year $500,000 unrestricted neuroscience research grant from the Bristol-Myers Squibb Company for research in the neurobiology, pharmacology and treatment of schizophrenia and related psychotic disorders.” (http://www.pnnonline.org/fundraising/unc061902.asp; accessed 10/01/02)
SCHOOL OF PUBLIC HEALTH
“University of North Carolina at Chapel Hill and the Gatorade Co. today (July 21, 2003) launched a $4 million, multi-year partnership — “Get Kids in Action” — whose goal is to identify successful strategies that will help reduce and prevent childhood obesity.... Gatorade is manufactured by PepsiCo Beverages and Foods, a division of PepsiCo. (http://www.unc.edu/news/newsserv/archives/jul03/gatorade072103.html; accessed 8/12/03)
CENTER FOR EXCELLENCE IN PHARMACOEPIDEMIOLOGY
CEP's establishment is made possible through the commitment of $3 million in funding over five years by GlaxoSmithKline (GSK).
Through the center, “UNC will develop courses as continuing education or distance learning opportunities for industry professionals, and GSK will sponsor graduate student internships in pharmacoepidemiology. In addition, talent from elsewhere in public health, as well as the schools of medicine and pharmacy, will be engaged with key GlaxoSmithKline staff from the Research Triangle Park, Philadelphia and other sites worldwide...?At times there will be a compelling need to foster research on an important topic that comes from GSK, and as they are identified, UNC and GlaxoSmithKline will negotiate an appropriate research contract,'....The center also will include a small [GSK] grant program to foster new collaborations and provide an opportunity to explore innovative research avenues.” (http://www.unc.edu/news/newsserv/archives/jan03/centerex011603.html; accessed 8/12/03)
The proposed organizational structure provides for a “Center Director [who] will provide intellectual leadership and immediate visibility to the enterprise, based at UNC, but also engages at GSK [and an] internal advisory board of key UNC and GSK representatives [to] oversee policy and address potential conflicts and other sensitive matters that might arise.” (Proposal for a Center for Excellence in Pharmaco-epidemiology: The University of North Carolina at Chapel Hill — GlaxoSmithKline. Received 08/03; On file with CSPI)